Nature analysis of publication patterns
paperAuthor
Credibility Rating
Gold standard. Rigorous peer review, high editorial standards, and strong institutional reputation.
Rating inherited from publication venue: Nature
While this Nature article covers a medical breakthrough in cystic fibrosis treatment, it is not directly relevant to AI safety research, policy, or governance.
Paper Details
Metadata
Summary
A Nature article reports that the developers of Trikafta, a triple-drug combination treatment for cystic fibrosis, have won a US$3-million Breakthrough Prize. Trikafta has proven transformative for approximately 90% of cystic fibrosis patients by targeting the malformed proteins at the root of the disease. The award recognizes this significant medical breakthrough that has substantially improved outcomes for people with this inherited disorder affecting the lungs and other organs.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| International AI Coordination Game Model | Analysis | 59.0 |
Cached Content Preview
Life-changing cystic fibrosis treatment wins US$3-million Breakthrough Prize
Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
Email
Bluesky
Facebook
LinkedIn
Reddit
Whatsapp
X
Access through your institution
Buy or subscribe
The triple-drug combination Trikafta has given a new lease of life to 90% of people with cystic fibrosis, an inherited disorder that affects the lungs and other organs. Now, the trio of researchers who spearheaded its development has won one of this year’s US$3-million Breakthrough prizes — the most lucrative awards in science.
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Learn more
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Learn more
Rent or buy this article
Prices vary by article type
from $1.95
to $39.95
Learn more
Prices may be subject to local taxes which are calculated during checkout
Nature 621 , 450-451 (2023)
doi: https://doi.org/10.1038/d41586-023-02890-1
References
Riordan, J. R. et al. Science 245 , 1066–1073 (1989).
Article
PubMed
Google Scholar
Lopez, A., Daly, D., Vega-Hernandez, G., MacGregor, G. & Rubin, J. L. J. Cyst. Fibros. 22 , 607–614 (2023).
Article
PubMed
Google Scholar
Keating, D. et al. N. Engl. J. Med. 379 , 1612–1620 (2018).
Article
PubMed
Google Scholar
Sidransky, E. et al. N. Engl. J. Med. 361 , 1651–1661 (2009).
Article
PubMed
Google Scholar
Gilks, W. P. et al. Lancet 365 , 415–416 (2005).
Article
PubMed
Google Scholar
Zimprich, A. et al. Neuron 44 , 601–607 (2004).
Article
PubMed
Google Scholar
Rizig, M. et al. Lancet Neurol . https://doi.org/10.1016/S1474-4422(23)00283-1 (2023).
Article
PubMed
Google Scholar
Brentjens, R. J. et al. Nature Med. 9 , 279–286 (2003).
Article
PubMed
Google Scholar
... (truncated, 9 KB total)51d88490769a4fc2 | Stable ID: ZGUxYjU2M2